Our Company Overview Investor Relations CareersPharma ServicesNeoGenomics offers lab services for oncology clinical trialsLearn moreCOVID-19Precision Medicine during this CrisisNeoGenomics and other organizations in the healthcare community unite to form COVID-19 testing industry consortium.Click here to viewLatest Presented: June 9, 2021 Source: Webinar Breast Cancer Tumor Board NeoGenomics is proud to offer our Molecular Tumor Boards covering relevant topics in cancer care.… Learn More Presented: June 2, 2021 Source: Webinar Lung Cancer Tumor Board NeoGenomics is proud to offer our Molecular Tumor Boards covering relevant topics in cancer care.… Learn More Presented: May 12, 2021 Source: Webinar Breast Cancer Tumor Board NeoGenomics is proud to offer our Molecular Tumor Boards covering relevant topics in cancer care.… Learn More Presented: May 5, 2021 Source: Webinar Lung Cancer Tumor Board NeoGenomics is proud to offer our Molecular Tumor Boards covering relevant topics in cancer care.… Learn More Presented: April 20, 2021 Source: Webinar NeoGenomics Diagnostic Symposium New Developments in Leukemia Learn More New Tests Image Available: March 22, 2021 Methodology: Immunohistochemistry (IHC) Melanoma Micromets Melanoma micrometastases (micromets) consist of small groups of melanoma cancer cells, originating… Learn More Image Available: March 22, 2021 Methodology: Immunohistochemistry (IHC) Carcinoma Micromets Carcinoma micrometastases (micromets) consist of small groups of cancer cells, originating from the… Learn More Image Available: February 8, 2021 Methodology: Cytogenetics Products of Conception (POC) Chromosome Analysis Chromosome abnormalities account for nearly one-half of first trimester spontaneous miscarriages,… Learn More Image Available: February 8, 2021 Methodology: Cytogenetics Constitutional Chromosome Analysis Constitutional chromosome analysis evaluates a patients’ cellular composition for normal-appearing… Learn More Image Available: January 25, 2021 Methodology: FISH HER2 (Other) Probes: HER2 (17q11.2-q12) | Centromere 17 (Cen 17) Disease(s): Endometrial cancer, salivary duct… Learn More
